The weed wire Preclinical results for InMed’s CBN glaucoma treatment show promise Studies showed CBN formulations reduced interocular pressure and protected retinal cells in the eye Nick LabaMay 27, 2020
Medical and Pharmaceutical Cannabinol (CBN) the main ingredient in potential treatments for glaucoma and a rare skin disease InMed Pharmaceuticals has initiated a clinical trial for its epidermolysis bullosa treatment, after regulatory approval in December Nick LabaJanuary 20, 2020